Identification of E-cadherin mutations in invasive lobular breast carcinoma (ILC).

被引：0
|
作者：
Droufakou, S
Deshmane, VH
Roylance, R
Hanby, AM
Sheer, D
Tomlinson, I
Hart, IR
机构：
[1] St Thomas Hosp, ICRF Lab, Richard Dimbleby Dept Canc Res, London, England
[2] Imperial Canc Res Fund, LIF 44, Human Cytogenet Lab, London, England
[3] Guys Hosp, Imperial Canc Res Fund, Breast Pathol Unit, London, England
[4] Imperial Canc Res Fund, LIF 44, Mol & Populat Genet Lab, London, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P26
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [41] Aberrant E-Cadherin Expression in Lobular Breast Carcinomas
    Struthers, K.
    O'Donnell, M.
    JOURNAL OF PATHOLOGY, 2010, 222 : S22 - S22
  • [42] E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations
    Grabenstetter, Anne
    Mohanty, Abhinita S.
    Rana, Satshil
    Zehir, Ahmet
    Brannon, A. Rose
    D'Alfonso, Timothy M.
    DeLair, Deborah F.
    Tan, Lee K.
    Ross, Dara S.
    HUMAN PATHOLOGY, 2020, 102 : 44 - 53
  • [43] Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast
    Palacios, J
    Sarrió, D
    García-Macias, MC
    Bryant, B
    Sobel, ME
    Merino, MJ
    MODERN PATHOLOGY, 2003, 16 (07) : 674 - 678
  • [44] Low incidence of germline and somatic alterations in the E-cadherin gene in lobular breast carcinoma
    Schmutzler, RK
    Derakhshandeh-Peykar, P
    Freihoff, D
    Brandau, O
    Meindl, A
    DISEASE MARKERS, 1999, 15 (1-3) : 123 - 123
  • [45] The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast
    Dabbs, David J.
    Kaplai, Malathy
    Chivukula, Mamatha
    Kanbour, Anisa
    Kanbour-Shakir, Amal
    Carter, Gloria J.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (03) : 260 - 266
  • [46] Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast - Reply
    Goldstein, NS
    CANCER, 2002, 94 (07) : 2115 - 2116
  • [47] Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations
    Corso, Giovanni
    De Scalzi, Alessandra
    Feroce, Irene
    Veronesi, Paolo
    Bonanni, Bernardo
    Galimberti, Viviana
    PERSONALIZED MEDICINE, 2018, 15 (03) : 153 - 155
  • [48] Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes
    Engstrom, Monica J.
    Opdahl, Signe
    Vatten, Lars J.
    Haugen, Olav A.
    Bofin, Anna M.
    HISTOPATHOLOGY, 2015, 66 (03) : 409 - 419
  • [49] Clinical implication of E-cadherin deficiency in lobular breast cancer
    Giovanni Corso
    Gabriella Pravettoni
    Viviana Galimberti
    Paolo Veronesi
    Breast Cancer Research and Treatment, 2019, 173 : 751 - 752
  • [50] E-cadherin mutations in gastric carcinoma - Reply
    Endoh, Y
    Tamura, G
    Watanabe, H
    Motoyama, T
    JOURNAL OF PATHOLOGY, 2000, 191 (04): : 467 - 468
12345